Laos Boten ElementoPharma is a comprehensive pharmaceutical enterprise of anti-tumor, antiviral and daily drugs.

Watch Our Story

ElementoPharma Limited

After the establishment of Laos ElementoPharma Co., Ltd. in 2019, it has attracted the attention of many Chinese patients, since it is a company founded by a technical teams consisting of deputy dean of Institute of Artificial Intelligence Biomedical Technology, Nanjing University, China, professors of industry, and PhDs in Cell Biology of the Chinese Academy of Sciences.
Laos ElementoPharma was established in the Boten Special Economic Zone of Laos. Laos Boten Economic Special Zone is located in the heartland of Indo-China Peninsula and borders on China, it is standing at the transportation hub of Indo-China Peninsula Economic Corridor and is gradually growing into an emerging hotbed for CAFTA and GMS. On August 31, 2015, governments of China and Laos officially entered into Overall Plan on Construction of China Laos Boten-Motin Economic Cooperation Zone. On November 28, 2016, both governments officially entered into Overall Plan on Co-development of China Laos Boten-Motin Economic Cooperation Zone (Outline). Establishment of China Laos Boten-Motin Economic Cooperation Zone is a major milestone for economic and trade cooperation between the two countries. With such a location, the pharmaceutical factories carry out strict production, so it can be trusted...... To learn more

生产最新的抗肿瘤类药物

It produces the latest anti-tumor medicines

提供丰富可靠肝炎类药物

It provides rich and reliable medicines for hepatitis

为全球提供合约生产服务

It provides contracted production services to the world

具有强烈社会责任感企业

Enterprise with a high sense of responsibility

Core Products

Capmatinib

Sotorasib

Molnupiravir

Favipiravir

Lorlatinib

Cabozantinib

Dacomtinib

Crizotinib

Lenvatinib

Talazoparib

Apalutamide

Selpercatinib

For more information, please click here